Unicycive Therapeutics Stock Cycle Indicators Hilbert Transform SineWave

UNCY Stock  USD 0.69  0.01  1.47%   
Unicycive Therapeutics cycle indicators tool provides the execution environment for running the Hilbert Transform SineWave indicator and other technical functions against Unicycive Therapeutics. Unicycive Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of cycle indicators indicators. As with most other technical indicators, the Hilbert Transform SineWave indicator function is designed to identify and follow existing trends. Cycle Indicators are used by chartists in order to analyze variations of the instantaneous phase or amplitude of Unicycive Therapeutics price series.

Indicator
The minimum time period for execution of this function requires larger time horizon. Please increase the time horizon for this function. The output start index for this execution was zero with a total number of output elements of zero. The Hilbert Transform - SineWave indicator is the sine of the Dominant Cycle Phase indicator which is used to generate in-phase and quadrature components of Unicycive Therapeutics price series.

Unicycive Therapeutics Technical Analysis Modules

Most technical analysis of Unicycive Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Unicycive from various momentum indicators to cycle indicators. When you analyze Unicycive charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Unicycive Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Unicycive Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Unicycive Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Unicycive Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Unicycive Therapeutics's daily price indicators and compare them against related drivers, such as cycle indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Unicycive Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Unicycive Therapeutics, we also check how macroeconomic factors affect Unicycive Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2024 (projected)
Interest Debt Per Share0.0040750.003871
Revenue Per Share0.02750.0498
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Unicycive Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.030.626.16
Details
Intrinsic
Valuation
LowRealHigh
0.071.456.99
Details
Naive
Forecast
LowNextHigh
0.020.786.33
Details
6 Analysts
Consensus
LowTargetHigh
3.493.834.25
Details

Learn to be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Portfolio Diagnostics Now

   

Portfolio Diagnostics

Use generated alerts and portfolio events aggregator to diagnose current holdings
All  Next Launch Module

Unicycive Therapeutics pair trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Unicycive Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Unicycive Therapeutics Pair Trading

Unicycive Therapeutics Pair Trading Analysis

The ability to find closely correlated positions to Unicycive Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Unicycive Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Unicycive Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Unicycive Therapeutics to buy it.
The correlation of Unicycive Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Unicycive Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Unicycive Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Unicycive Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Unicycive Stock Analysis

When running Unicycive Therapeutics' price analysis, check to measure Unicycive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unicycive Therapeutics is operating at the current time. Most of Unicycive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Unicycive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Unicycive Therapeutics' price. Additionally, you may evaluate how the addition of Unicycive Therapeutics to your portfolios can decrease your overall portfolio volatility.